Thus, circ_0086414 inhibited EC cell malignancy through the miR-1290/SPARCL1_athway, providing a reliable target for the therapy of EC.
Circular_0086414 induces SPARC like 1 (SPARCL1) production to inhibit esophageal cancer cell proliferation, invasion and glycolysis and induce cell apoptosis by sponging miR-1290.